2021-02-18

Onconova Therapeutics, Newton, Pennsylvania. 1,077 likes · 1 talking about this · 1 was here. Onconova Therapeutics, Inc. (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on

Onconova Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing novel products candidates to treat cancer. Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. Aktieägare i de relaterade bolagen äger också aktier i Onconova Therapeutics Inc. Andelen 7 % anger hur många av Synthetic Biologics Inc-ägarna som även har Onconova Therapeutics Inc i sin portfölj. Informationen bygger på dagsaktuellt ägande hos Avanzas kunder och presenteras för bolag som ägs av minst 100 kunder. 2021-03-22 2021-02-16 Onconova Therapeutics, Inc. February 16, 2021 GMT NEWTOWN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced the closing of its previously-announced underwritten public offering. 2021-02-08 2020-12-01 Onconova Therapeutics is a clinical-stage biopharma company that's focused on developing products for cancer care.

Its efforts are focused on disrupting key cellular pathways that play a Our Opinion. Onconova Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in discovery and All information about Onconova Therapeutics: stock price Onconova Therapeutics, quote chart Onconova Therapeutics, company dividends Onconova Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing novel drugs to treat cancer. Onconova has a pipeline of 6 Dec 2019 Inceptua and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Countries Outside the US. Onconova Therapeutics (ONTX). $0.72. -0.10 (-12.72%). As of April 12 4:00:00 PM EST. License Error: Access from crawling bot.

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation.

About Onconova Therapeutics, Inc. Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. 2021-02-17 · Onconova Therapeutics (ONTX) stock is on the rise Wednesday following the closing of its most recent public offering of 28.75 million shares. 2021-02-10 · Press Release Onconova Therapeutics, Inc. Announces Pricing of $25 Million Public Offering of Common Stock Published: Feb. 10, 2021 at 10:49 p.m.

2021-02-18

Onconova Therapeutics, Inc. (NASDAQ:ONTX) trade information. Upright in the green during last session for gaining 3.3%, in the last five days ONTX remained trading in the green while hitting it’s week-highest on Thursday, Apr 08 when the stock touched $0.8695 price level, adding 20.4% to its value on the day.

Investors’ optimism about the company’s current quarter earnings report is understandable.
Gam etf

Post-Market 0.02 (3.19%) Onconova Therapeutics, Newton, Pennsylvania. 1,077 likes · 1 talking about this · 1 was here. Onconova Therapeutics, Inc. (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on 2021-02-10 · NEWTOWN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to 2021-04-13 · Onconova Therapeutics (ONTX) stock is on the rise Wednesday following the closing of its most recent public offering of 28.75 million shares. The post ONTX Stock: Why Biopharma Onconova Therapeutics Is 2021-01-14 · About Onconova Therapeutics, Inc. Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing novel products for patients with cancer. Onconova Therapeutics Inc Announces Pricing Of $25 Million Public Offering Of Common Stock.

24t7d1m3m1å5å. Köp / Sälj. Aktiekampen.
Avanza fondrobot

2020-08-24

flegmatic. 26 augusti 06:41 sålde Onconova Therapeutics, Inc. till kurs 0,29 USD. Handla Gilla (0) Följ tråd Kommentera Dölj kommentarer.

Java direkt ausführen

Artiklar, analyser, telegram, pressreleaser och analytikernas aktieråd rörande Onconova Therapeutics, Inc.

Onrox group malm malm: ab, frn kunder reco.